The partnership establishes a framework to strengthen local manufacturing and resilience
The Emirates Drug Establishment (EDE) and Arcera Life Sciences (Arcera) have announced the signing of a Memorandum of Understanding (MoU) to strengthen pharmaceutical manufacturing capabilities in the UAE.
Signed at Make it in the Emirates, taking place May 4-7, 2026, at ADNEC Centre Abu Dhabi, the agreement establishes a framework for collaboration across local manufacturing, talent development, research and innovation, and the strategic supply of medical products.
Under the MoU, both parties will work together to advance capacity building and Emiratization within the UAE’s pharmaceutical sector. This includes training programs, technical exchanges, workshops, and industry initiatives aimed at equipping Emirati talent with the skills required for advanced manufacturing environments.
Key initiatives
As part of the agreement, Arcera will sponsor key initiatives led by the Emirates Drug Establishment and contribute to programs that strengthen the pharmaceutical manufacturing sector. This includes establishing training pathways within its manufacturing facilities to support workforce readiness and future employment.
“This partnership allows us to translate those priorities into tangible impact for patients and communities we serve,” commented Isabel Afonso, CEO, Arcera.
